` Comparison: NYKD vs EPE - Alpha Spread

N
NYKD
vs
E
EPE

Over the past 12 months, NYKD has significantly outperformed EPE, delivering a return of +78% compared to the EPE's 0% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
NYKD
EPE
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

NYKD Intrinsic Value
HIDDEN
Show
EPE Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
N
Nykode Therapeutics ASA
OSE:NYKD
2.844 NOK
E
Epizyme Inc
F:EPE
559 EUR
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
NYKD, EPE

NYKD
EPE
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
N
Nykode Therapeutics ASA
Revenue
E
Epizyme Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
NYKD, EPE

NYKD
EPE
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
N
Nykode Therapeutics ASA
OSE:NYKD
E
Epizyme Inc
F:EPE
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

NYKD
0%
EPE
75.6%
LTM 3Y Avg 5Y Avg 10Y Avg
N
Nykode Therapeutics ASA
E
Epizyme Inc

Operating Margin

NYKD
-391.2%
EPE
-370.1%
LTM 3Y Avg 5Y Avg 10Y Avg
N
Nykode Therapeutics ASA
E
Epizyme Inc

Net Margin

NYKD
-162.5%
EPE
-391.9%
LTM 3Y Avg 5Y Avg 10Y Avg
N
Nykode Therapeutics ASA
E
Epizyme Inc

FCF Margin

NYKD
-522.3%
EPE
-394.1%
LTM 3Y Avg 5Y Avg 10Y Avg
N
Nykode Therapeutics ASA
E
Epizyme Inc

ROE

NYKD
-9.1%
EPE
-877.5%
LTM 3Y Avg 5Y Avg 10Y Avg
N
Nykode Therapeutics ASA
E
Epizyme Inc

ROA

NYKD
-8%
EPE
-67.4%
LTM 3Y Avg 5Y Avg 10Y Avg
N
Nykode Therapeutics ASA
E
Epizyme Inc

ROIC

NYKD
-24.6%
EPE
-181.7%
LTM 3Y Avg 5Y Avg 10Y Avg
N
Nykode Therapeutics ASA
E
Epizyme Inc

ROCE

NYKD
-20.9%
EPE
-72.5%
LTM 3Y Avg 5Y Avg 10Y Avg
N
Nykode Therapeutics ASA
E
Epizyme Inc

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
NYKD, EPE

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
NYKD, EPE

Performance Gap Between NYKD and EPE
HIDDEN
Show

Performance By Year
NYKD, EPE

Loading
NYKD
EPE
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare NYKD to other stocks
PNEXF
Pharnext SCA
GILD
Gilead Sciences Inc
Custom
Choose any stock to compare
Unlock Full Access to Alpha Spread
Create Free Account